Enoxaparin (Clexane) contamination: latest information

Updated information on supply and clinical advice on enoxaparin (Clexane) pre-filled syringes, contaminated with over-sulphated-chondroitin sulphate (OSCS).

• From: Medicines and Healthcare products Regulatory Agency
• Published: 11 December 2014

• Therapeutic area: Cardiovascular disease and lipidology

Article date: July 2008

On June 6, 2008, we issued further information about the supply and prescribing of enoxaparin (Clexane), see http://www.mhra.gov.uk/Publications/Safetywarnings/Drugalerts/CON017989 with clarification at
http://www.mhra.gov.uk/Publications/Safetywarnings/Drugalerts/CON018050.

Further to the drug alerts issued by the Medicines and Healthcare products Regulatory Agency (MHRA) on 24 April and 9 May

Article citation: Drug Safety Update July 2008; Vol 1, Issue 12: 9

Published 11 December 2014